MREO

Mereo BioPharma Group plc Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares

Mereo BioPharma Group plc Announces Pricing of Public Offering of American Depositary Shares

Mereo BioPharma and Ultragenyx Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta

Mereo BioPharma Provides Update on AIM Delisting and Continued Listing of its ADSs on Nasdaq, and Provides Update on agreements with Silicon Valley Bank and Kreos Capital

Mereo BioPharma Appoints Suba Krishnan, M.D. as Senior Vice President of Clinical Development

Mereo BioPharma to Hold Virtual R&D Day on Tuesday, November 24, 2020